Livemint EN

Sai Parenteral's IPO: From GMP to key dates, price band, peers and more - 10 key things to know before subscribing

Sai Parenteral's ₹409 crore IPO opens for subscription on March 24, 2026, with a price band of ₹372-392 per share. The company plans to use the funds for expansion, R&amp;D, and working capital, with shares expected to list on April 2, 2026.

Mar 23, 2026 &03392323202631; 05:39 UTC www.livemint.com Trending 2/5

Read original on www.livemint.com ↗

→

Neutral impact

Sentiment score: 0/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Sai Parenteral, an Indian pharmaceutical company, is launching a ₹409 crore IPO with subscription opening March 24, 2026 at ₹372-392 per share, targeting listing on April 2, 2026. Funds will support expansion, R&D, and working capital initiatives in the parenteral drugs sector.

AI CONFIDENCE

65% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

⇅

SAIPARENTERAL.BO

SAIPARENTERAL.BOStock

High volatility expected

New IPO listing creates typical volatility during subscription and listing phases; actual direction depends on GMP performance, market conditions, and peer valuations not detailed in headline

⇅

FTSE MIB (Italy)

FTSEMIB.MIIndex

High volatility expected

Minimal direct impact on European indices; Indian pharmaceutical IPO activity has negligible influence on EU markets

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Monitor GMP performance and peer valuations before subscription. IPO pricing appears reasonable for parenteral pharma sector, but subscription demand and listing-day volatility are unpredictable. Consider waiting for listing stabilization before entry unless strong GMP signals emerge.

KEY SIGNALS

IPO subscription opens March 24, 2026Price band ₹372-392 per shareExpected listing April 2, 2026₹409 crore capital raiseFunds allocated to expansion and R&DGMP (Grey Market Premium) data not provided in headline

SECTORS INVOLVED

PharmaceuticalsHealthcareParenteral Drugs

Analysis generated on Mar 23, 2026 at 05:43 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Livemint. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Sai Parenteral's IPO: From GMP to key dates, price band, peers and more - 10 key things to know before subscribing

RELATED INTELLIGENCE